semaglutide and osteoporosis GLP-1 weight loss drugs could increase risk of gout, new research finds Frontiers | Use of GLP-1

Wegovy, is an injection made of semaglutide, a compound that mimics a satiety-inducing gut hormone that acts on the brain to reduce appetite

Some observational studies have suggested associations between regular consumption of artificially sweetened beverages and increased risk of type 2 diabetes, though these findings do not establish causation and may reflect confounding factors such as overall dietary patterns or reverse causality, where individuals at higher risk of diabetes choose diet beverages

Some providers may still have stock from before the legal cutoff

You can also ask a member of your care team to send you an invitation